{"id":"NCT02008890","sponsor":"Novartis Pharmaceuticals","briefTitle":"Palmoplantar Pustular Psoriasis Efficacy and Safety With Secukinumab","officialTitle":"A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab to Demonstrate Efficacy as Assessed by Palmoplantar Pustulosis Psoriasis Area and Severity Index (ppPASI) at 16 Weeks of Treatment, Compared to Placebo, and to Assess Long-term Safety, Tolerability, and Efficacy in Subjects With Moderate to Severe Chronic Palmoplantar Pustular Psoriasis - Amended With an Optional Extension Treatment Period of up to a Total of 148 Weeks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-12-26","primaryCompletion":"2014-11-24","completion":"2017-05-31","firstPosted":"2013-12-11","resultsPosted":"2019-01-04","lastUpdate":"2019-01-04"},"enrollment":237,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Palmoplantar Pustular Psoriasis"],"interventions":[{"type":"BIOLOGICAL","name":"Secukinumab 300mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Secukinumab 150mg","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Secukinumab 300mg","type":"EXPERIMENTAL"},{"label":"Secukinumab 150mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A one year study assessing the efficacy and safety of secukinumab compared with placebo in adult patients with moderate to severe palmoplantar pustular psoriasis - amended with an optional extension treatment period of up to a total of 148 weeks","primaryOutcome":{"measure":"Percentage of Participants With ppPASI 75 Response at Week 16 (Period 1)","timeFrame":"Baseline to Week 16","effectByArm":[{"arm":"AIN457 150mg","deltaMin":17.5,"sd":null},{"arm":"AIN457 300mg","deltaMin":26.6,"sd":null},{"arm":"Placebo","deltaMin":14.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.5722"},{"comp":"OG001 vs OG002","p":"0.0411"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":68,"countries":["Austria","Belgium","France","Germany","Italy","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":80},"commonTop":["Viral upper respiratory tract infection","Pustular psoriasis","Headache","Pruritus","Bronchitis"]}}